These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
687 related articles for article (PubMed ID: 24409314)
1. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. Liao J; Qian F; Tchabo N; Mhawech-Fauceglia P; Beck A; Qian Z; Wang X; Huss WJ; Lele SB; Morrison CD; Odunsi K PLoS One; 2014; 9(1):e84941. PubMed ID: 24409314 [TBL] [Abstract][Full Text] [Related]
2. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439 [TBL] [Abstract][Full Text] [Related]
3. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids. Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433 [No Abstract] [Full Text] [Related]
4. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells. Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949 [TBL] [Abstract][Full Text] [Related]
5. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Abubaker K; Latifi A; Luwor R; Nazaretian S; Zhu H; Quinn MA; Thompson EW; Findlay JK; Ahmed N Mol Cancer; 2013 Mar; 12():24. PubMed ID: 23537295 [TBL] [Abstract][Full Text] [Related]
6. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells. Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344 [TBL] [Abstract][Full Text] [Related]
7. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties. Hirst J; Pathak HB; Hyter S; Pessetto ZY; Ly T; Graw S; Koestler DC; Krieg AJ; Roby KF; Godwin AK Cancer Res; 2018 Aug; 78(15):4370-4385. PubMed ID: 29891506 [TBL] [Abstract][Full Text] [Related]
8. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869 [TBL] [Abstract][Full Text] [Related]
9. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin. He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Feng D; Peng C; Li C; Zhou Y; Li M; Ling B; Wei H; Tian Z Oncol Rep; 2009 Nov; 22(5):1129-34. PubMed ID: 19787230 [TBL] [Abstract][Full Text] [Related]
12. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors. Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974 [TBL] [Abstract][Full Text] [Related]
13. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289 [TBL] [Abstract][Full Text] [Related]
14. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis. Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933 [TBL] [Abstract][Full Text] [Related]
15. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance. Ward Rashidi MR; Mehta P; Bregenzer M; Raghavan S; Fleck EM; Horst EN; Harissa Z; Ravikumar V; Brady S; Bild A; Rao A; Buckanovich RJ; Mehta G Neoplasia; 2019 Aug; 21(8):822-836. PubMed ID: 31299607 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Wang L; Mezencev R; Bowen NJ; Matyunina LV; McDonald JF Mol Cell Biochem; 2012 Apr; 363(1-2):257-68. PubMed ID: 22160925 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer. Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658 [TBL] [Abstract][Full Text] [Related]
18. ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature. Roy L; Samyesudhas SJ; Carrasco M; Li J; Joseph S; Dahl R; Cowden Dahl KD Oncotarget; 2014 Sep; 5(18):8355-66. PubMed ID: 25327563 [TBL] [Abstract][Full Text] [Related]
20. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel. Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]